skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

51 Total results for product and free and sample content found

Pink Sheet

With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says

By Derrick Gingery 08 Dec 2020

Covid19 Biden Transition

As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.

Topic Coronavirus Vaccines US Election 2020

Scrip

Quick Listen: Scrip's Five Must-Know Things

By Ian Haydock 08 Dec 2020

Scrip August Podcast

Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things

Topic Coronavirus Vaccines Research & Development

Scrip

Precious Cargo: DHL Gears To Deliver COVID-19 Vaccines

By Anju Ghangurde 08 Dec 2020

DHL Covid-19 Vaccines

A senior executive shares insights around how the global logistics provider is preparing to deliver the upcoming COVID-19 vaccines across the world. While the company has prior experience with the "deep frozen" temperatures needed for some candidates, there will still be specific challenges and complexities involved. 

Topic Coronavirus Vaccines Distribution

Scrip

UK Grants First Worldwide Authorization For Pfizer/BioNTech COVID-19 Vaccine

By Andrew McConaghie 08 Dec 2020

Covid19 vaccine BioNTech

The UK's MHRA has granted an emergency authorization to the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.

Topic Coronavirus Vaccines

Pink Sheet

Vaccine Distribution Priorities To Rely On Governors, Not ACIP, HHS Secretary Azar Says

By Derrick Gingery 29 Nov 2020

covid19 vaccines distribution

Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated

Topic Vaccines Coronavirus Distribution

HBW Insight

UK Researchers Seek Commercial Partner For Nasal Spray Shown To 'Prevent' COVID-19

By Tom Gallen 29 Nov 2020

covid19 nasal spray R&D

A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.

Topic Coronavirus Research & Development Vaccines OTC Drugs

Scrip

Quick Listen: Scrip's Five Must-Know Things

By Ian Haydock 29 Nov 2020

Scrip August Podcast

Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things

Topic Coronavirus Research & Development Vaccines

Scrip

Russia Prepares $10 COVID-19 Vaccine For International Launch

By Andrew McConaghie 29 Nov 2020

covid19 russian vaccine

Russia is promising the best of both worlds – a low price with a near-perfect efficacy. While the basic science is plausible, its best-in-class claims are bound to generate skepticism

Topic Coronavirus Vaccines

Scrip

Oxford/AZ's COVID-19 Vaccine Cuts Virus Spread By 60%

By Vibha Sharma 29 Nov 2020

Covid19 Vaccine oxfordAZ

Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.

Topic Coronavirus Vaccines

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: